CDKN1B and glioblastoma: As far as downregulated genes were concerned, coculturing with GBM decreased the differences between control and Axitinib-treated HUVECs, in the case of LMNB1 likely because of its higher expression in transwell controls, and in the case of CDKN1B because of its lower expression in controls grown in the presence of GBM.